EXPERIMENTAL AND IN SILICO APPROACHES TO TARGET SELECTION AND TRACTABILITY FOR DRUG DISCOVERY

The CEO of Awridian will be attended this SMR meeting on Monday 21st March 2022 at the Francis Crick Institute in London UK .